Charlotte-based Dentsply Sirona appointed Daniel Scavilla as president and CEO, effective Aug. 1, according to an SEC filing. Scavilla succeeds Simon Campion, who has held those jobs since September 2022 and is leaving on July 31.
The manufacturer of dental products and technologies, has been restructuring for more than a year. Last July, Dentsply Sirona announced it would lay off as many as 640 of its 16,000 global employees, expecting annual savings of as much as $100 million. In February, it announced it wanted to sell or merge its Swedish-based Wellspect Healthcare business, which provides treatments for bladder and bowel dysfunction, to focus on the dental sector Dentsply acquired that business in 2011.
“There is significant, untapped opportunity across the dental market, and we believe that Dan is the right leader to help accelerate the company’s business transformation, reposition Dentsply Sirona as an industry leader and deliver long-term value creation,” says board Chair Gregory Lucier in a release.
Scavilla has worked at Audubon, Pennsylvania-based Globus Medical since 2015 after 28 years at Johnson & Johnson. He had been CEO since 2022. He joined Dentsply’s board in February. “The board and I are aligned in our belief that, while our ongoing transformation is yielding results, there is more we can do to drive commercial, operational and financial performance across the organization,” Scavilla says in a release.
Campion was an executive at Becton, Dickinson & Co. and C.R. Bard before joining Dentsply. Shares have declined 41% over the past year, closing Monday at $15.63.
“The board and I are aligned in our belief that, while our ongoing transformation is yielding results, there is more we can do to drive commercial, operational and financial performance across the organization,” Scavilla says in a release.
Scavilla led publicly traded Globus’s $3 billion acquisition of NuVasive, which created the second-largest spine technology company in the world, according to a release.
Globus Medical has a market capitalization of approximately $7.1 billion, compared with $3.1 billion for Dentsply.
Scavilla received a bachelor’s degree from LaSalle University and an MBA from Temple University, both in Philadelphia.
Scavilla’s target pay at Dentsply is $7.75 million, compared with the $4.85 million he earned in 2024 at Globus. He will also receive an equity grant worth about $6.4 million, along with an “additional signing bonus” representing a portion of a $1.6 million bonus he is forfeiting by leaving Globus. He’ll also receive $150,000 to defray the cost of moving to North Carolina. Campion earned approximately $8.7 million from Dentsply in 2024.